 |
PDBsum entry 4mjs
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Transferase/protein binding
|
PDB id
|
|
|
|
4mjs
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
(+ 6 more)
88 a.a.
|
 |
|
|
|
|
|
|
|
82 a.a.
|
 |
|
|
|
|
|
|
|
84 a.a.
|
 |
|
|
|
|
|
|
|
87 a.a.
|
 |
|
|
|
|
|
|
|
|
|
|
|
References listed in PDB file
|
 |
|
Key reference
|
 |
|
Title
|
 |
Structural and biochemical insights into the homotypic pb1-Pb1 complex between pkcζ and p62.
|
 |
|
Authors
|
 |
J.Ren,
J.Wang,
Z.Wang,
J.Wu.
|
 |
|
Ref.
|
 |
Sci China Life Sci, 2014,
57,
69-80.
[DOI no: ]
|
 |
|
PubMed id
|
 |
|
 |
|
|
 |
 |
|
Abstract
|
 |
|
The atypical PKC isoforms (ζ and ı) play essential roles in regulating various
cellular processes. Both the hetero-interaction between PKCζ and p62 through
their N-terminal PB1 domains and the homo-oligomerization of p62 via its PB1
domain are critical for the activation of NF-κB signaling; however, the
molecular mechanisms concerning the formation and regulation of these homotypic
complexes remain unclear. Here we determined the crystal structure of PKCζ-PB1
in complex with a monomeric p62-PB1 mutant, where the massive electrostatic
interactions between the acidic OPCA motif of PKCζ-PB1 and the basic surface of
p62-PB1, as well as additional hydrogen bonds, ensure the formation of a stable
and specific complex. The PKCζ-p62 interaction is interfered with the
modification of a specific Cys of PKCζ by the antiarthritis drug
aurothiomalate, though all four cysteine residues in the PKCζ-PB1 domain can be
modified in in vitro assay. In addition, detailed structural and biochemical
analyses demonstrate that the PB1 domains of aPKCs belong to the type I group,
which can depolymerize the high-molecular-weight p62 aggregates into
homo-oligomers of lower order. These data together unravel the molecular
mechanisms of the homo-or hetero-interactions between p62 and PKCζ and provide
the basis for designing inhibitors of NF-κB signaling.
|
 |
|
|
|
|
 |